CoapTech, founded to revolutionize medical procedures, focuses on developing innovative medical devices using its patented Point-of-care Ultrasound Magnet Aligned (PUMA) System. The company's core mission is to enhance global healthcare by making procedures easier, faster, and safer, thereby reducing healthcare costs. CoapTech's flagship product, the PUMA-G System, facilitates safer gastrostomy procedures and is targeted at critical care physicians and interventional radiologists.

Notable figures affiliated with CoapTech include its founders and key investors who have supported its growth in the medical device sector. The company has achieved significant milestones, including regulatory approvals and successful clinical trials, which underscore its impact on improving patient care. CoapTech's innovations have the potential to disrupt multiple medical procedures, positioning it as a transformative player in the healthcare industry.